CXCR4 and neoplasm: The disruption of CXCR4/CXCL12 signaling can enhance the efficacy of chemotherapy and immunotherapy by blunting the migration and metastasis of tumor cells and remodeling of the immunosuppressive tumor microenvironment (TME) [9].